Body Handbook Catalogue Profile Ranking
Screening BODY HANDBOOK
Screening ยท ยง128
Lab Ranges: Normal vs. Optimal
Your lab report prints a number and a "normal" range that isn't a doctor's idea of health. It's the middle 95% of a few hundred people the lab called healthy, so 5% of the healthy land outside it by design CLSI 2010. Run a 14-test panel and the odds one healthy value flags red pass 50%. The tighter "optimal" ranges are sometimes real, sometimes a machine for turning healthy people into patients. How you read it beats any single number on the page.
Know Evidence Moderate Chapter Screening

The range is a screening filter, not a verdict. The lower bound is the 2.5th percentile of that sampled group, the upper the 97.5th 1. The group was recruited by self-report, so it already carries low-grade inflammation and quiet deficiencies nobody screened for. In range can mean you sit in a population that is, on average, mildly unwell.

"Optimal" ranges are built backward, from where values sit in people with the best outcomes. Usually narrower, sometimes by a factor of two. Whether the tighter window earns its keep comes down to one question, biomarker by biomarker: has anyone tested that treating the gap actually helps?

Ferritin is the case where narrower wins. The lab calls it low around 15โ€“30; the optimal floor is pushed to 50 or more. Menstruating women with unexplained fatigue and ferritin between 15 and 50 improve on iron despite a "normal" report โ€” roughly half their fatigue gone 2. If that's you, the report is wrong about you.

TSH is the case where narrower collapses. The standard ceiling is about 4.5; clinics target under 2.5. But TSH rises with age 3, and treating the gap did nothing for symptoms, energy, or heart events 4. Around 21 million Americans take levothyroxine and most probably don't need it 5.

Vitamin D is the case that quietly reversed. Five years of 2,000 IU a day dropped neither cancer nor heart disease 6, and the 2024 guideline dropped the 30 ng/mL target for healthy adults and advised against routine testing 7.

Read your own report in this order.

Read labs well and the freed-up time and money go where the larger effect sizes actually live: sleep, training, food, the people around you.

The fine print โ€” when to skip it, and what people get wrong

Both directions cost. Trusting every green check hides iron deficiency for years. Chasing every number snowballs: 99% of physicians report cascades from incidental findings, 94% ending in nothing important 9; Korean thyroid screening drove a 15-fold diagnosis jump with no change in deaths 10.

"In range means healthy." It can mean the 51st percentile of a mildly unwell population. "Out of range means sick." Or the assay drifted, or you ate before a fasting test. "Narrower is more accurate." Narrower is more sensitive at the cost of flagging more healthy people, and only pays if intervention there helps.

References
  1. 1CLSI (2010). Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline (EP28-A3c). link
  2. 2Krayenbuehl PA, Battegay E, Breymann C, Furrer J, Schulthess G (2011). Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration. Blood. link
  3. 3Surks MI, Hollowell JG (2007). Age-Specific Distribution of Serum Thyrotropin and Antithyroid Antibodies in the U.S. Population: Implications for the Prevalence of Subclinical Hypothyroidism. Journal of Clinical Endocrinology & Metabolism. link
  4. 4Stott et al. (2017). Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism (TRUST). New England Journal of Medicine. link
  5. 5Brito et al. (2021). Levothyroxine Use in the United States, 2008โ€“2018. JAMA Internal Medicine. link
  6. 6Manson et al. (2019). Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease (VITAL). New England Journal of Medicine. link
  7. 7Demay et al. (2024). Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism. link
  8. 8Fraser CG (2011). Reference change values. Clinical Chemistry and Laboratory Medicine. link
  9. 9Ganguli I, Simpkin AL, Lupo C, Weissman A, Mainor AJ, Orav EJ, Rosenthal MB, Colla CH, Sequist TD (2019). Cascades of Care After Incidental Findings in a US National Survey of Physicians. JAMA Network Open. link
  10. 10Ahn HS, Kim HJ, Welch HG (2014). Korea's Thyroid-Cancer "Epidemic" โ€” Screening and Overdiagnosis. New England Journal of Medicine. link
ยท
128